* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Design and Synthesis of Small Molecule Inhibitors of
Discovery and development of direct thrombin inhibitors wikipedia , lookup
Discovery and development of tubulin inhibitors wikipedia , lookup
Pharmacognosy wikipedia , lookup
Discovery and development of cephalosporins wikipedia , lookup
Discovery and development of HIV-protease inhibitors wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
MTOR inhibitors wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
DNA-encoded chemical library wikipedia , lookup
Drug design wikipedia , lookup
Discovery and development of non-nucleoside reverse-transcriptase inhibitors wikipedia , lookup
Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Discovery and development of dipeptidyl peptidase-4 inhibitors wikipedia , lookup
Discovery and development of direct Xa inhibitors wikipedia , lookup
Drug discovery wikipedia , lookup
Discovery and development of integrase inhibitors wikipedia , lookup
Metalloprotease inhibitor wikipedia , lookup
Discovery and development of neuraminidase inhibitors wikipedia , lookup
Discovery and development of ACE inhibitors wikipedia , lookup
Poster No. 48 Title: Design and Synthesis of Small Molecule Inhibitors of Endothelial Lipase, an HDL Regulating Drug Target Authors: Daniel O'Connell and William Bachovchin Presented by: Daniel O'Connell Department(s): Department of Biochemistry, Tufts University School of Medicine Abstract: Endothelial Lipase (EL) is a recently discovered member of the triglyceride lipase gene family whose activity is negatively correlated with levels of HDL-cholesterol in vivo. Disruption of EL activity, either through antibody directed inhibition, or gene knock-out, has been shown to increase levels of HDL-C in rabbits and mice on both normal and high-fat diets. Because the active site of EL contains serine-protease like achitecture, we hypothesized that boronic acids could be used as small molecule inhibitors. Indeed, several aliphatic and arylboronic acids have been synthesized and screened against EL and its highly homologous family member, lipoprotein lipase (LPL). Since our initial screens, we have synthesized rationally designed derivatives of phenylboronic acid. The best of these compounds shows IC50 = 1µM, while also being 42-fold more selective for EL than LPL. The next generation of compounds will incorporate negatively charged moieties into these inhibitors in an attempt to capitalize on the preference of EL for phospholipids. These syntheses will take advantage of a newly developed synthetic scheme that incorporates significant recent advances of the Suzuki coupling. It is our hope that these inhibitors could be used as novel therapeutics to raise HDL-cholesterol levels. 50